NCT06123390

Brief Summary

The purpose of this study is to evaluate the effect of the Responses to Illness Severity Quantification (RISQ) system implementation on mortality and processes of care in a nutritional program treating children 6 to 59 months of age with acute malnutrition in Ngouri, Chad.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 11, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

October 26, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

November 8, 2023

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2024

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

12 months

First QC Date

October 26, 2023

Last Update Submit

November 28, 2023

Conditions

Keywords

decision supportmortalityillness severityrisk score

Outcome Measures

Primary Outcomes (1)

  • All-cause mortality.

    Mortality over the period beginning at admission to the program and ending at either program discharge or to a maximum of 60 days after study enrolment. Program discharge will be one of: \[1\] medical/anthropometric criteria or \[2\] defaulting from the program. Defaulting from the program is defined as children who do not attend the weekly clinic visits for 3 consecutive weeks.

    12 months

Secondary Outcomes (8)

  • Timing of inpatient mortality

    Duration of hospitalization in days up to 60 days

  • Timing of outpatient mortality

    Duration of program inclusion in days up to 60 days

  • Therapeutic intensity

    First 24 hours from admission to hospital

  • Efficiency of inpatient care

    Duration of hospitalization in days up to 60 days

  • Workload

    Month 1 and month 12

  • +3 more secondary outcomes

Other Outcomes (4)

  • Lived experience of RISQ System implementation

    one time at end of 12 month implementation period

  • comparison of automated versus manual measurements of vital signs (Respiratory rate in breaths/min)

    During run-in phase prior to implementation of intervention, on average 2 months

  • comparison of automated versus manual measurements of vital signs (Temperature in degrees Celsius)

    During run-in phase prior to implementation of intervention, on average 2 months

  • +1 more other outcomes

Study Arms (2)

Usual Care

NO INTERVENTION

The 17 health centres randomized to "Usual Care" will provide care as per OptiMA program.

Intervention Arm

EXPERIMENTAL

The 17 health centres randomized to the intervention arm will provide care as per OptiMA program with the addition of the RISQ System decision support.

Other: The Responses to Illness Severity Quantification (RISQ) System

Interventions

The RISQ System involves: \[1\] the RISQ score: calculated routinely using the \[2\] documentation record and linked to \[3\] score-matched recommendations. Introduction into clinical care is supported by \[4\] the RISQ System implementation package. During the 2 month prior to implementation, front-line staff in the intervention arm will be trained on and will practice the use of the RISQ System .

Intervention Arm

Eligibility Criteria

Age6 Months - 59 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children:
  • age: 6 to 59 months at enrolment on the day of their admission/re-admission to the OptiMA program
  • written consent to participate
  • Front line staff providing care to patients enrolled in the Optima program:
  • \[1\] Registered Nurses \[2\] Medical Doctors

You may not qualify if:

  • Children:
  • Children allergic to milk, peanuts and/or ready-to-use therapeutic food (RUTF)
  • Children not residing in one of the study areas.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ngouri

Ngouri, Chad

RECRUITING

Related Publications (3)

  • Dale NM, Ashir GM, Maryah LB, Shepherd S, Tomlinson G, Briend A, Zlotkin S, Parshuram C. Development and an initial validation of the Responses to Illness Severity Quantification (RISQ) score for severely malnourished children. Acta Paediatr. 2022 Sep;111(9):1752-1763. doi: 10.1111/apa.16410. Epub 2022 Jun 3.

    PMID: 35582782BACKGROUND
  • Dale NM, Ashir GM, Maryah LB, Shepherd S, Tomlinson G, Briend A, Zlotkin S, Parshuram CS. Evaluating the Validity of the Responses to Illness Severity Quantification Score to Discriminate Illness Severity and Level of Care Transitions in Hospitalized Children with Severe Acute Malnutrition. J Pediatr. 2023 Nov;262:113609. doi: 10.1016/j.jpeds.2023.113609. Epub 2023 Jul 5.

    PMID: 37419241BACKGROUND
  • Dale NM, Hagre YD, Shepherd S, Tomlinson G, Zlotkin S, Ngaradoum M, Bechir M, Madjissem M, Tehoua C, Parshuram C. Cluster-randomized trial of the implementation of the Responses to Illness Severity Quantification (RISQ) system in children with acute malnutrition 6 to 59 months of age in Ngouri, Chad: the CRIMSON trial protocol. Trials. 2025 Jun 3;26(1):188. doi: 10.1186/s13063-025-08871-1.

Related Links

MeSH Terms

Conditions

Severe Acute Malnutrition

Interventions

Drug Delivery Systems

Condition Hierarchy (Ancestors)

MalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeutics

Study Officials

  • Christopher Parshuram, MD, PhD

    The Hospital for Sick Children

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nancy M Dale, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The participants and care providers will know which arm of the study they are part of, as the randomization occurs at the facility level. Only the statistician will be blinded to the arms at the time of analysis.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: In this study we are evaluating usual care (Arm 1) vs. the Responses to Illness Severity Quantification (Arm 2) in children children aged 6 to 59 months who are enrolled in the OptiMA nutrition program in Chad. Community health centres will be the randomized clusters.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Physician, Paediatric Intensive Care Unit, Department of Critical Care Medicine

Study Record Dates

First Submitted

October 26, 2023

First Posted

November 8, 2023

Study Start

September 11, 2023

Primary Completion

August 31, 2024

Study Completion

October 31, 2024

Last Updated

November 29, 2023

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

On reasonable request - after publication of the study and with permission of parties attached to the study, and after Research Ethics Board review and approval.

Locations